In order to patent a new chemical compound, which is to be used for medical purposes, it is necessary to present already in the patent application the results of a research confirming its therapeutic effects.

In the latest issue of the magazine “The World of Pharmaceutical Industry” (“Świat Przemysłu Farmaceutycznego”) Barbara Milczarek, a patent attorney at Patpol, discussed the obligation of a sufficient disclosure of invention in the context of the application procedures.

We invite you to read the full article in polish.

?TO BE OR NOT TO BE? when it comes to trademarks, or what should be remembered to guarantee genuine use of a trademark [Article on IP-Blog.pl]

Author: Joanna Rafalska, Polish and European Trade Mark and Design Attorney When a party is Czytaj dalej

PATPOL IP RUNNERS inaugurated the season of this year’s charity relay!

Last Saturday, nearly 8,000 runners from over 550 companies united in a common sports passion Czytaj dalej

Happy Easter!

As Easter is approaching, we wish you a lot of joy, peace and optimism. Let Czytaj dalej